Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sirenas LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11330
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature’s chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of nature’s chemistry. Its pipeline products are used for sting pathway antagonist, t-cell activation, infectious disease and innate immunity. The company uses its pipeline products for immuno-oncology and infectious disease programs.It partners with pharmaceutical companies and research foundations to widen the use of its ATLANTI technology. Sirenas is headquartered in San Diego, California, the US.

Sirenas LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Partnerships 11
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC – Key Competitors 13
Sirenas LLC – Key Employees 14
Sirenas LLC – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Dec 13, 2017: Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Sirenas LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Sirenas LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sirenas Marine Raises Us$1.3 Million In Venture Financing 10
Sirenas Enters into Research Agreement wiith Bristol-Myers Squibb 11
Sirenas to Enter into Agreement with California Institute for Biomedical Research 12
Sirenas LLC, Key Competitors 13
Sirenas LLC, Key Employees 14

List of Figures
Sirenas LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirenas LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirenas LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lowe’s Companies, Inc.:戦略・SWOT・企業財務分析
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Novartis AG (NOVN)-製薬・医療分野:企業M&A・提携分析
    Summary Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, n …
  • University of Glasgow-製薬・医療分野:企業M&A・提携分析
    Summary University of Glasgow (UOG) is an educational and research institute that offers undergraduate, post graduate, and online programs. The institute operates through its departments for law, medicine, veterinary medicine and dentistry. It offers courses across various disciplines that include a …
  • Tecan Group Ltd (TECN)-医療機器分野:企業M&A・提携分析
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Archroma Management GmbH:企業の戦略的SWOT分析
    Archroma Management GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Edwards Lifesciences Corp (EW)-医療機器分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mitsubishi Logistics Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Yahoo Japan Corporation (4689):企業の財務・戦略的SWOT分析
    Yahoo Japan Corporation (4689) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Avista Corporation:企業の戦略・SWOT・財務分析
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Distell Group Limited:戦略・SWOT・企業財務分析
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cook Medical Inc:企業の戦略的SWOT分析
    Cook Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務分析
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Genetic Signatures Ltd (GSS):企業の製品パイプライン分析
    Summary Genetic Signatures Ltd (Genetic Signatures) formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It off …
  • KrisEnergy Holdings Ltd (SK3):企業の財務・戦略的SWOT分析
    Summary KrisEnergy Holdings Ltd (KrisEnergy) is an independent upstream company that production and development of oil and gas in the basins. The company discovers, appraises, develops and produces hydrocarbon resources. It services comprise development and production of identifying potential prospe …
  • KCA Deutag Alpha Ltd:企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆